FDA CLEARANCE

Advertisement
Jan 05 2026BUSINESS

Inspira's Big Move into Cancer Detection

Inspira Technologies is making a bold step into the cancer diagnostics field. They've signed a preliminary deal to buy a company that specializes in liquid biopsy technology. This tech can detect cancer cells in blood samples using AI. The deal also includes a $15 million investment from an unnamed

reading time less than a minute